3.9 Article

Clinical findings of equine leukoencephalomalacia

Journal

PESQUISA VETERINARIA BRASILEIRA
Volume 41, Issue -, Pages -

Publisher

REVISTA PESQUISA VETERINARIA BRASILEIRA
DOI: 10.1590/1678-5150-PVB-6912

Keywords

Leukoencephalomalacia; equine; epidemiological aspects; clinical aspects

Funding

  1. Veterinary Hospital of the Faculdade de Medicina e Zootecnia, Universidade Estadual Paulista Julio de Mesquita Filho (FMVZ-Unesp), Botucatu/SP

Ask authors/readers for more resources

Equine leukoencephalomalacia is a disease caused by ingesting fumonisin-contaminated food, mainly affecting horses. Clinical signs include acute onset and rapid evolution of brain injuries, with altered mental state and behavioral disturbance as the main symptoms.
Equine leukoencephalomalacia (LEM) is a disease caused by the ingestion of food, especially corn, contaminated by fumonisin, a Fusarium verticillioides (synonymous with F. moniliforme) metabolite. The clinical signs of brain injuries have an acute onset and rapid evolution. This study aimed to describe the clinical findings in 11 animals diagnosed with LEM, including cerebrospinal fluid (CSF) analysis. Of these animals, 91% (10/11) were horses, and only 9% (1/11) were asinine. The clinical localization of the lesions was 64% (7/10) cerebral, manifested mainly by altered mental state and behavioral disturbance, and 36% (4/11) were brainstem lesions, manifested by incoordination, head tilt, nystagmus, facial hypoalgesia, difficulty in apprehension, chewing, and swallowing food. Postmortem findings revealed that 82% (9/11) of the lesions were in the cerebrum and 18% (2/11) in the brainstem. CSF findings, such as xanthochromia (43%, 3/7), hyperproteinorrachia (50%, 3/6), and pleocytosis (43%, 3/7) were observed. The affected animals showed neurological signs that were compatible with cerebral and/or brainstem injuries. The CSF from animals with LEM may present with xanthochromia, hyperproteinorrachia, and pleocytosis, reinforcing the fact that this disease should be included in the differential diagnosis of encephalomyelopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available